{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:48:44Z","timestamp":1790394524120,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2474-11-276","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T20:00:03Z","timestamp":1294257603000},"source":"Crossref","is-referenced-by-count":26,"title":["Enhancement of antinociception by coadminstration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in na\u00efve mice and murine models of LPS-induced thermal hyperalgesia and monoarthritis"],"prefix":"10.1186","volume":"11","author":[{"given":"Ala'a Ahmed","family":"Abu-Ghefreh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willias","family":"Masocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,1]]},"reference":[{"issue":"2","key":"1022_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","volume":"54","author":"AN Sapadin","year":"2006","unstructured":"Sapadin AN, Fleischmajer R: Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006, 54 (2): 258-265. 10.1016\/j.jaad.2005.10.004.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1022_CR2","first-page":"611","volume":"22","author":"M Kloppenburg","year":"1995","unstructured":"Kloppenburg M, Mattie H, Douwes N, Dijkmans BA, Breedveld FC: Minocycline in the treatment of rheumatoid arthritis: relationship of serum concentrations to efficacy. J Rheumatol. 1995, 22 (4): 611-616.","journal-title":"J Rheumatol"},{"issue":"5","key":"1022_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2165\/00002018-200022050-00007","volume":"22","author":"P Langevitz","year":"2000","unstructured":"Langevitz P, Livneh A, Bank I, Pras M: Benefits and risks of minocycline in rheumatoid arthritis. Drug Saf. 2000, 22 (5): 405-414. 10.2165\/00002018-200022050-00007.","journal-title":"Drug Saf"},{"issue":"10","key":"1022_CR4","first-page":"2112","volume":"30","author":"M Stone","year":"2003","unstructured":"Stone M, Fortin PR, Pacheco-Tena C, Inman RD: Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity. J Rheumatol. 2003, 30 (10): 2112-2122.","journal-title":"J Rheumatol"},{"issue":"6","key":"1022_CR5","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/ard.2009.127225","volume":"69","author":"C Gaujoux-Viala","year":"2010","unstructured":"Gaujoux-Viala C, Smolen JS, Landewe R, Dougados M, Kvien TK, Mola EM, Scholte-Voshaar M, van Riel P, Gossec L: Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2010, 69 (6): 1004-1009. 10.1136\/ard.2009.127225.","journal-title":"Ann Rheum Dis"},{"issue":"2-3","key":"1022_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejphar.2007.01.013","volume":"560","author":"J Mika","year":"2007","unstructured":"Mika J, Osikowicz M, Makuch W, Przewlocka B: Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol. 2007, 560 (2-3): 142-149. 10.1016\/j.ejphar.2007.01.013.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1022_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1124\/jpet.103.052407","volume":"306","author":"V Raghavendra","year":"2003","unstructured":"Raghavendra V, Tanga F, DeLeo JA: Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther. 2003, 306 (2): 624-630. 10.1124\/jpet.103.052407.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1-3","key":"1022_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejphar.2007.07.049","volume":"576","author":"LF Bastos","year":"2007","unstructured":"Bastos LF, Merlo LA, Rocha LT, Coelho MM: Characterization of the antinociceptive and anti-inflammatory activities of doxycycline and minocycline in different experimental models. Eur J Pharmacol. 2007, 576 (1-3): 171-179. 10.1016\/j.ejphar.2007.07.049.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1022_CR9","doi-asserted-by":"publisher","first-page":"R310","DOI":"10.1186\/ar1483","volume":"7","author":"WT Chen","year":"2005","unstructured":"Chen WT, Mahmood U, Weissleder R, Tung CH: Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res Ther. 2005, 7 (2): R310-317. 10.1186\/ar1483.","journal-title":"Arthritis Res Ther"},{"issue":"11-12","key":"1022_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.lfs.2009.07.015","volume":"85","author":"W Masocha","year":"2009","unstructured":"Masocha W, Parvathy SS: Assessment of weight bearing changes and pharmacological antinociception in mice with LPS-induced monoarthritis using the Catwalk gait analysis system. Life Sci. 2009, 85 (11-12): 462-469. 10.1016\/j.lfs.2009.07.015.","journal-title":"Life Sci"},{"issue":"3","key":"1022_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1476-5381.1992.tb14503.x","volume":"107","author":"FQ Cunha","year":"1992","unstructured":"Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH: The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol. 1992, 107 (3): 660-664.","journal-title":"Br J Pharmacol"},{"issue":"1-3","key":"1022_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ejphar.2007.07.007","volume":"573","author":"TM Cunha","year":"2007","unstructured":"Cunha TM, Verri WA, Fukada SY, Guerrero AT, Santodomingo-Garzon T, Poole S, Parada CA, Ferreira SH, Cunha FQ: TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor. Eur J Pharmacol. 2007, 573 (1-3): 221-229. 10.1016\/j.ejphar.2007.07.007.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1022_CR13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/j.1476-5381.1993.tb13946.x","volume":"110","author":"SH Ferreira","year":"1993","unstructured":"Ferreira SH, Lorenzetti BB, Poole S: Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol. 1993, 110 (3): 1227-1231.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1022_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00401-006-0135-z","volume":"112","author":"LH Guo","year":"2006","unstructured":"Guo LH, Schluesener HJ: Acute but not chronic stimulation of glial cells in rat spinal cord by systemic injection of lipopolysaccharide is associated with hyperalgesia. Acta Neuropathol. 2006, 112 (6): 703-713. 10.1007\/s00401-006-0135-z.","journal-title":"Acta Neuropathol"},{"issue":"2-3","key":"1022_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0304-3959(99)00238-9","volume":"84","author":"RS Talhouk","year":"2000","unstructured":"Talhouk RS, Hajjar L, Abou-Gergi R, Simaa'n CJ, Mouneimne G, Saade NE, Safieh-Garabedian B: Functional interplay between gelatinases and hyperalgesia in endotoxin-induced localized inflammatory pain. Pain. 2000, 84 (2-3): 397-405. 10.1016\/S0304-3959(99)00238-9.","journal-title":"Pain"},{"issue":"1-2","key":"1022_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0304-3959(01)00433-X","volume":"96","author":"D Sachs","year":"2002","unstructured":"Sachs D, Cunha FQ, Poole S, Ferreira SH: Tumour necrosis factor-alpha, interleukin-1beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. Pain. 2002, 96 (1-2): 89-97. 10.1016\/S0304-3959(01)00433-X.","journal-title":"Pain"},{"issue":"3","key":"1022_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/sj.bjp.0702347","volume":"126","author":"S Poole","year":"1999","unstructured":"Poole S, Lorenzetti BB, Cunha JM, Cunha FQ, Ferreira SH: Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br J Pharmacol. 1999, 126 (3): 649-656. 10.1038\/sj.bjp.0702347.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1022_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0014-2999(87)90606-6","volume":"135","author":"M Nakamura","year":"1987","unstructured":"Nakamura M, Ferreira SH: A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol. 1987, 135 (2): 145-153. 10.1016\/0014-2999(87)90606-6.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"1022_CR19","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1046\/j.1471-4159.1999.02206.x","volume":"73","author":"A Inoue","year":"1999","unstructured":"Inoue A, Ikoma K, Morioka N, Kumagai K, Hashimoto T, Hide I, Nakata Y: Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J Neurochem. 1999, 73 (5): 2206-2213.","journal-title":"J Neurochem"},{"issue":"6 Suppl 25","key":"1022_CR20","first-page":"S9","volume":"19","author":"M Dougados","year":"2001","unstructured":"Dougados M: The role of anti-inflammatory drugs in the treatment of osteoarthritis: a European viewpoint. Clin Exp Rheumatol. 2001, 19 (6 Suppl 25): S9-14.","journal-title":"Clin Exp Rheumatol"},{"issue":"8-10","key":"1022_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/BF02944294","volume":"25","author":"KF Daoud","year":"1999","unstructured":"Daoud KF, Jackson CG, Williams HJ: Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs. Compr Ther. 1999, 25 (8-10): 427-433. 10.1007\/BF02944294.","journal-title":"Compr Ther"},{"issue":"Suppl 1","key":"1022_CR22","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar1908","volume":"8","author":"BN Cronstein","year":"2006","unstructured":"Cronstein BN, Terkeltaub R: The inflammatory process of gout and its treatment. Arthritis Res Ther. 2006, 8 (Suppl 1): S3-10.1186\/ar1908.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1022_CR23","first-page":"54","volume":"14","author":"MB Yunus","year":"1988","unstructured":"Yunus MB: Current therapeutic practices in spondyloarthropathies. Compr Ther. 1988, 14 (2): 54-64.","journal-title":"Compr Ther"},{"issue":"2","key":"1022_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1096\/fasebj.1.2.3111928","volume":"1","author":"J Vane","year":"1987","unstructured":"Vane J, Botting R: Inflammation and the mechanism of action of anti-inflammatory drugs. Faseb J. 1987, 1 (2): 89-96.","journal-title":"Faseb J"},{"issue":"6","key":"1022_CR25","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/sj.bjp.0702897","volume":"128","author":"JA Mitchell","year":"1999","unstructured":"Mitchell JA, Warner TD: Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol. 1999, 128 (6): 1121-1132. 10.1038\/sj.bjp.0702897.","journal-title":"Br J Pharmacol"},{"key":"1022_CR26","unstructured":"Ferreira SH: Peripheral analgesic sites of action of anti-inflammatory drugs. Int J Clin Pract Suppl. 2002, 2-10. 128"},{"issue":"3","key":"1022_CR27","first-page":"247","volume":"59","author":"H Suleyman","year":"2007","unstructured":"Suleyman H, Demircan B, Karagoz Y: Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol Rep. 2007, 59 (3): 247-258.","journal-title":"Pharmacol Rep"},{"issue":"Suppl 5","key":"1022_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2165\/00003495-199400475-00006","volume":"47","author":"K McCormack","year":"1994","unstructured":"McCormack K: The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects. Drugs. 1994, 47 (Suppl 5): 28-45. 10.2165\/00003495-199400475-00006. discussion 46-27.","journal-title":"Drugs"},{"issue":"1","key":"1022_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/BF01630485","volume":"44","author":"LA Pini","year":"1995","unstructured":"Pini LA, Sandrini M, Vitale G: Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat. Inflamm Res. 1995, 44 (1): 30-35. 10.1007\/BF01630485.","journal-title":"Inflamm Res"},{"key":"1022_CR30","first-page":"1","volume":"103","author":"R Bjorkman","year":"1995","unstructured":"Bjorkman R: Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. Acta Anaesthesiol Scand Suppl. 1995, 103: 1-44.","journal-title":"Acta Anaesthesiol Scand Suppl"},{"issue":"3","key":"1022_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/PL00000287","volume":"51","author":"M Sandrini","year":"2002","unstructured":"Sandrini M, Vitale G, Pini LA: Effect of rofecoxib on nociception and the serotonin system in the rat brain. Inflamm Res. 2002, 51 (3): 154-159. 10.1007\/PL00000287.","journal-title":"Inflamm Res"},{"issue":"1","key":"1022_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874467210902010001","volume":"2","author":"M Hamza","year":"2009","unstructured":"Hamza M, Dionne RA: Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition. Curr Mol Pharmacol. 2009, 2 (1): 1-14. 10.2174\/1874467210902010001.","journal-title":"Curr Mol Pharmacol"},{"issue":"2","key":"1022_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983, 16 (2): 109-110. 10.1016\/0304-3959(83)90201-4.","journal-title":"Pain"},{"issue":"1-2","key":"1022_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0014-2999(00)00051-0","volume":"391","author":"T Ochi","year":"2000","unstructured":"Ochi T, Motoyama Y, Goto T: The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models. Eur J Pharmacol. 2000, 391 (1-2): 49-54. 10.1016\/S0014-2999(00)00051-0.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1022_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/sj.bjp.0706715","volume":"148","author":"A Wibberley","year":"2006","unstructured":"Wibberley A, McCafferty GP, Evans C, Edwards RM, Hieble JP: Dual, but not selective, COX-1 and COX-2 inhibitors, attenuate acetic acid-evoked bladder irritation in the anaesthetised female cat. Br J Pharmacol. 2006, 148 (2): 154-161. 10.1038\/sj.bjp.0706715.","journal-title":"Br J Pharmacol"},{"key":"1022_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/ddr.9","volume":"51","author":"AG Habeeb","year":"2000","unstructured":"Habeeb AG, Rao PNP, Knaus EE: Design and syntheses of diarylisoxazoles: novel inhibitors of cyclooxygenase-2 (COX-2) with analgesic-antiinflammatory activity. Drug Dev Res. 2000, 51: 273-286. 10.1002\/ddr.9.","journal-title":"Drug Dev Res"},{"issue":"2","key":"1022_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/08977150150502613","volume":"18","author":"FP Hamers","year":"2001","unstructured":"Hamers FP, Lankhorst AJ, van Laar TJ, Veldhuis WB, Gispen WH: Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma. 2001, 18 (2): 187-201. 10.1089\/08977150150502613.","journal-title":"J Neurotrauma"},{"issue":"8","key":"1022_CR38","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1523\/JNEUROSCI.21-08-02580.2001","volume":"21","author":"T Tikka","year":"2001","unstructured":"Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J: Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci. 2001, 21 (8): 2580-2588.","journal-title":"J Neurosci"},{"issue":"5","key":"1022_CR39","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1128\/AAC.50.5.1798-1804.2006","volume":"50","author":"W Masocha","year":"2006","unstructured":"Masocha W, Rottenberg ME, Kristensson K: Minocycline impedes African trypanosome invasion of the brain in a murine model. Antimicrob Agents Chemother. 2006, 50 (5): 1798-1804. 10.1128\/AAC.50.5.1798-1804.2006.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1022_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2174\/0929867013373598","volume":"8","author":"ME Ryan","year":"2001","unstructured":"Ryan ME, Usman A, Ramamurthy NS, Golub LM, Greenwald RA: Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity. Curr Med Chem. 2001, 8 (3): 305-316.","journal-title":"Curr Med Chem"},{"issue":"1","key":"1022_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0006-2952(96)00168-2","volume":"52","author":"L Paemen","year":"1996","unstructured":"Paemen L, Martens E, Norga K, Masure S, Roets E, Hoogmartens J, Opdenakker G: The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. Biochem Pharmacol. 1996, 52 (1): 105-111. 10.1016\/0006-2952(96)00168-2.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1022_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/BF02980066","volume":"27","author":"SS Kim","year":"2004","unstructured":"Kim SS, Kong PJ, Kim BS, Sheen DH, Nam SY, Chun W: Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells. Arch Pharm Res. 2004, 27 (3): 314-318. 10.1007\/BF02980066.","journal-title":"Arch Pharm Res"},{"issue":"3","key":"1022_CR43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2340\/16501977198618107116","volume":"18","author":"E Olsson","year":"1986","unstructured":"Olsson E, Goldie I, Wykman A: Total hip replacement. A comparison between cemented (Charnley) and non-cemented (HP Garches) fixation by clinical assessment and objective gait analysis. Scand J Rehabil Med. 1986, 18 (3): 107-116.","journal-title":"Scand J Rehabil Med"},{"issue":"4","key":"1022_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0268-0033(95)91401-Y","volume":"10","author":"L Weidenhielm","year":"1995","unstructured":"Weidenhielm L, Svensson OK, Brostrom Lk L: Surgical correction of leg alignment in unilateral knee osteoarthrosis reduces the load on the hip and knee joint bilaterally. Clin Biomech (Bristol, Avon). 1995, 10 (4): 217-221. 10.1016\/0268-0033(95)91401-Y.","journal-title":"Clin Biomech (Bristol, Avon)"},{"issue":"3","key":"1022_CR45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1365-2249.1995.tb03864.x","volume":"102","author":"M Kloppenburg","year":"1995","unstructured":"Kloppenburg M, Verweij CL, Miltenburg AM, Verhoeven AJ, Daha MR, Dijkmans BA, Breedveld FC: The influence of tetracyclines on T cell activation. Clin Exp Immunol. 1995, 102 (3): 635-641. 10.1111\/j.1365-2249.1995.tb03864.x.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1022_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/cimm.1996.0027","volume":"167","author":"KL Sewell","year":"1996","unstructured":"Sewell KL, Breedveld F, Furrie E, O'Brien J, Brinckerhoff C, Dynesius-Trentham R, Nosaka Y, Trentham DE: The effect of minocycline in rat models of inflammatory arthritis: correlation of arthritis suppression with enhanced T cell calcium flux. Cell Immunol. 1996, 167 (2): 195-204. 10.1006\/cimm.1996.0027.","journal-title":"Cell Immunol"},{"issue":"2","key":"1022_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/0003-4819-122-2-199501150-00001","volume":"122","author":"BC Tilley","year":"1995","unstructured":"Tilley BC, Alarcon GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, Clegg DO, Leisen JC, Buckley L, Cooper SM: Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med. 1995, 122 (2): 81-89.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1022_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00124743-199908000-00011","volume":"5","author":"SM Cooper","year":"1999","unstructured":"Cooper SM: A perspective on the use of minocycline for rheumatoid arthritis. J Clin Rheumatol. 1999, 5 (4): 233-237. 10.1097\/00124743-199908000-00011. discussion 237-238","journal-title":"J Clin Rheumatol"},{"issue":"Suppl 1","key":"1022_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2165\/00003495-198800351-00004","volume":"35","author":"TJ Daymond","year":"1988","unstructured":"Daymond TJ, Rowell FJ: Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment. Drugs. 1988, 35 (Suppl 1): 4-8. 10.2165\/00003495-198800351-00004.","journal-title":"Drugs"},{"issue":"14","key":"1022_CR50","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1097\/00001756-200410050-00007","volume":"15","author":"Y Song","year":"2004","unstructured":"Song Y, Wei EQ, Zhang WP, Zhang L, Liu JR, Chen Z: Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. Neuroreport. 2004, 15 (14): 2181-2184. 10.1097\/00001756-200410050-00007.","journal-title":"Neuroreport"},{"issue":"2","key":"1022_CR51","first-page":"128","volume":"44","author":"M Bishnoi","year":"2006","unstructured":"Bishnoi M, Patil CS, Kumar A, Kulkarni SK: Potentiation of antinociceptive effect of NSAIDs by a specific lipooxygenase inhibitor, acetyl 11-keto-beta boswellic acid. Indian J Exp Biol. 2006, 44 (2): 128-132.","journal-title":"Indian J Exp Biol"},{"key":"1022_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1744-8069-5-35","volume":"5","author":"L Guasti","year":"2009","unstructured":"Guasti L, Richardson D, Jhaveri M, Eldeeb K, Barrett D, Elphick MR, Alexander SP, Kendall D, Michael GJ, Chapman V: Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. Mol Pain. 2009, 5: 35-10.1186\/1744-8069-5-35.","journal-title":"Mol Pain"},{"issue":"2-3","key":"1022_CR53","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0014-2999(02)02485-8","volume":"454","author":"H Guhring","year":"2002","unstructured":"Guhring H, Hamza M, Sergejeva M, Ates M, Kotalla CE, Ledent C, Brune K: A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol. 2002, 454 (2-3): 153-163. 10.1016\/S0014-2999(02)02485-8.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1022_CR54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0304-3959(97)00213-3","volume":"75","author":"JD Richardson","year":"1998","unstructured":"Richardson JD, Kilo S, Hargreaves KM: Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain. 1998, 75 (1): 111-119. 10.1016\/S0304-3959(97)00213-3.","journal-title":"Pain"},{"issue":"2-3","key":"1022_CR55","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0014-2999(01)00988-8","volume":"419","author":"A Calignano","year":"2001","unstructured":"Calignano A, La Rana G, Piomelli D: Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol. 2001, 419 (2-3): 191-198. 10.1016\/S0014-2999(01)00988-8.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"1022_CR56","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jpain.2008.12.012","volume":"10","author":"L Chen","year":"2009","unstructured":"Chen L, Zhang J, Li F, Qiu Y, Wang L, Li YH, Shi J, Pan HL, Li M: Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats. J Pain. 2009, 10 (7): 732-739. 10.1016\/j.jpain.2008.12.012.","journal-title":"J Pain"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-11-276\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-11-276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-11-276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-11-276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T19:20:26Z","timestamp":1712085626000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-11-276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1022"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-11-276","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"article-number":"276"}}